Abstract
Aims
The aim of this study was to investigate subclinical left ventricular (LV) changes between type 2 diabetic patients with or without obesity using three-dimensional speckle-tracking echocardiography (3DSTE).
Methods
A total of 77 type 2 diabetic patients, including 36 subjects with BMI < 25 kg/m2 and 41 subjects with BMI ≥ 25 kg/m2, as well as 40 age- and sex-matched controls (BMI: 18.5 ~ 24.5 kg/m2) were studied. Waist circumference was measured in diabetic patients with a BMI ≥ 25 kg/m2 to determine whether abdominal obesity as a complication was present. Real-time three-dimensional (3D) full volume images of the left ventricle were recorded and analyzed. Left ventricular ejection fraction (LVEF), global longitudinal strain (GLS), global circumferential strain (GCS), global area strain (GAS), and global radial strain (GRS) were calculated and compared.
Results
Compared with the controls, diabetic subjects without overall obesity had significantly lower GCS, GAS, and GRS (p < 0.05), as well as markedly lower GLS (p < 0.001). However, 3D-LVEF and all global strains in diabetic subjects with overall obesity were not only markedly lower compared with controls (p < 0.002 and p < 0.001), but also significantly lower than those in diabetic subjects without overall obesity (p < 0.002 and p < 0.05). HbA1c and BMI showed negative impacts on all strains in diabetic patients. Meanwhile, the diabetic subjects with overall and abdominal obesity had significantly reduced GLS, GCS, GAS, and GRS compared with those with overall obesity only (all p < 0.05).
Conclusions
Type 2 diabetic patients demonstrated early-stage subclinical LV deformation and dysfunction, whilst coexistent obesity resulted in further damage to myocardial contractility and reduced LVEF. 3DSTE was a sensitive method for detecting these abnormalities.
Zusammenfassung
Ziel
Ziel der Studie war es, subklinische linksventrikuläre (LV) Veränderungen bei Typ-2-Diabetes-Patienten mit oder ohne Adipositas unter Einsatz der dreidimensionalen Speckle-Tracking-Echokardiographie (3DSTE) zu untersuchen.
Methoden
Es wurden 77 Typ-2-Diabetes-Patienten, darunter 36 Teilnehmer mit einem Body-Mass-Index (BMI) < 25 kg/m2 und 41 Teilnehmer mit einem BMI ≥ 25 kg/m2, sowie 40 in Alter und Geschlecht entsprechende Kontrollen (BMI: 18,5 ~ 24,5 kg/m2) untersucht. Ob bei den Diabetespatienten mit einem BMI ≥ 25 kg/m2 die Komplikation einer abdominellen Adipositas vorlag, hing vom Taillenumfang ab. Ein 3-D-Echtzeit-full-Volume-Datensatz des linken Ventrikels wurde dokumentiert und analysiert. Die linksventrikuläre Ejektionsfraktion (LVEF), globale longitudinale Deformation („global longitudinal strain“, GLS), globale zirkumferenzielle Deformation („global circumferential strain“, GCS), globale flächige Deformation („global area strain“, GAS) und globale radiale Deformation („global radial strain“, GRS) wurden berechnet und verglichen.
Ergebnisse
Verglichen mit den Kontrollen wiesen Diabetespatienten ohne allgemeine Adipositas eine signifikant niedrigere GCS, GAS und GRS (p < 0,05) sowie eine deutlich niedrigere GLS auf (p < 0,001). Jedoch waren die 3D-LVEF und alle globalen Deformationen bei Diabetespatienten mit allgemeiner Adipositas nicht nur deutlich niedriger als bei den Kontrollen (p < 0,002 bzw. p < 0,001), sondern auch signifikant niedriger als bei den Diabetespatienten ohne allgemeine Adipositas (p < 0,002 bzw. p < 0,05). Der HbA1c-Wert und der BMI hatten negative Auswirkungen auf alle Deformationen bei Diabetespatienten. Bei den Diabetespatienten mit allgemeiner und abdomineller Adipositas waren GLS, GCS, GAS und GRS im Vergleich zu den Werten bei allgemeiner Adipositas allein signifikant vermindert (alle p < 0,05).
Schlussfolgerung
Die Typ-2-Diabetes-Patienten wiesen eine subklinische LV-Verformung und -Funktionsstörung im frühen Stadium auf, und eine begleitende Adipositas führte zu einer weiteren Schädigung der Myokardkontraktilität sowie zu einer verminderten LVEF. Die 3DSTE stellte sich als sensitives Verfahren zur Erkennung dieser Auffälligkeiten heraus.
References
Whalley GA, Gusso S, Hofman P et al (2009) Structural and functional cardiac abnormalities in adolescent girls with poorly controlled type 2 diabetes. Diabetes Care 32:883–888
Alpert MA, Lambert CR, Panayiotou H et al (1995) Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 76:1194–1197
Ryden L, Grant PJ, Anker SD et al (2013) ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 34:3035–3087
Miyoshi H, Oishi Y, Mizuguchi Y et al (2014) Contribution of obesity to left atrial and left ventricular dysfunction in asymptomatic patients with hypertension: a two-dimensional speckle-tracking echocardiographic study. J Am Soc Hypertens 8:54–63
Geetha L, Deepa M, Anjana RM et al (2011) Prevalence and clinical profile of metabolic obesity and phenotypic obesity in Asian Indians. J Diabetes Sci Technol 5:439–446
Du T, Sun X, Yin P et al (2013) Increasing trends in central obesity among Chinese adults with normal body mass index, 1993–2009. BMC Public Health 13:327
Niu J, Seo DC (2014) Central obesity and hypertension in Chinese adults: a 12-year longitudinal examination. Prev Med 62:113–118
Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115:3213–3223
Scholte AJ, Nucifora G, Delgado V et al (2011) Subclinical left ventricular dysfunction and coronary atherosclerosis in asymptomatic patients with type 2 diabetes. Eur J Echocardiogr 12:148–155
Nakai H, Tacheuchi M, Nishikage T et al (2009) Subclinical left ventricular dysfunction in asymptomatic diabetic patients assessed by two—dimensional speckle tracking echocardiography: correlation with diabetic duration. Eur J Echocardiogr 10:926–932
Pala S, Esen O, Akcakoyun M et al (2010) Rosiglitazone, but not pioglitazone, improves myocardial systolic function in type 2 diabetic patients: a tissue Doppler study. Echocardiography 27:512–518
Zoroufian A, Razmi T, Taghavi-Shavazi M et al (2014) Evaluation of subclinical left ventricular dysfunction in diabetic patients: longitudinal strain velocities and left ventricular dyssynchrony by two-dimensional speckle tracking echocardiography study. Echocardiography 31:456–463
Ernande L, Bergerot C, Girerd N et al (2014) Impaired longitudinal myocardial strain alteration is associated with left ventricular remodeling in asymptomatic patients with type 2 diabetes mellitus. J Am Soc Echocardiogr 27:479–488
Helle-Valle T, Crosby J, Edvardsen T et al (2005) New noninvasive method for assessment of left ventricular rotation: speckle tracking echocardiography. Circulation 112:3149–3156
Breaker SJ (2000) The importance of long axis ventricular function. Heart 84:577–578
Yan GH, Wang M, Yiu KH et al (2012) Subclinical left ventricular dysfunction revealed by circumferential 2D strain imaging in patients with coronary artery disease and fragmented QRS complex. Heart Rhythm 9:928–935
Deng YB, Liu R, Wu YH et al (2010) Evaluation of short-axis and long-axis myocardial function with two-dimensional strain echocardiography in patients with different degrees of coronary artery stenosis. Ultrasound Med Biol 36:227–233
Zhang X, Wei X, Liang Y et al (2013) Differential changes of left ventricular myocardial deformation in diabetic patients with controlled and uncontrolled blood glucose: a three-dimensional speckle-tracking echocardiography—based study. J Am Soc Echocardiogr 26:499–506
Deng Y, Alharthi MS, Thota VR et al (2010) Evaluation of left ventricular rotation in obese subjects by velocity vector imaging. Eur J Echocardiogr 11:424–428
Cil H, Bulur S, Turker Y et al (2012) Impact of body mass index on left ventricular diastolic dysfunction. Echocardiography 29:647–651
Mehta SK, Richards N, Lorber R et al (2009) Abdominal obesity, waist circumference, body mass index, and echocardiographic measures in children and adolescents. Congenit Heart Dis 4:338–347
Hao PP, Chen YG, Liu YP et al (2013) Association of plasma angiotensin-(1–7) level and left ventricular function in patients with type 2 diabetes mellitus. PLoS One 8:e62788
Vinereanu D, Madler CF, Gherghinescu C et al (2011) Cumulative impact of cardiovascular risk factors on regional left ventricular function and reserve: progressive long-axis dysfunction with compensatory radial changes. Echocardiography 28:813–820
Marwick TH (2006) Diabetic heart disease. Heart 92:296–300
Kaczmarczyk SJ, Andrikopoulos S, Favaloro J et al (2003) Threshold effects of glucose transporter-4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy. J Mol Endocrinol 31:449–459
Sheikh AQ, Hurley JR, Huang W et al (2012) Diabetes alters intracellular calcium transients in cardiac endothelial cells. PLoS One 7:e36840
Dillmann WH (1989) Diabetes and thyroid-hormone-induced changes in cardiac function and their molecular basis. Annu Rev Med 40:373–394
Connelly KA, Kelly DJ, Zhang Y et al (2009) Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy. Circ Heart Fail 2:129–137
MacGowan GA, Shapiro EP, Azhari H et al (1997) Noninvasive measurement shortening in the fiber and cross-fiber directions in the normal human left ventricle and in idiopathic dilated cardiomyopathy. Circulation 96:535–541
Li CM, Li C, Bai WJ et al (2013) Value of three-dimensional speckle-tracking in detecting left ventricular dysfunction in patients with aortic valvular diseases. J Am Soc Echocardiogr 26:1245–1252
Kissebah AH, Krakower GR (1994) Regional adiposity and morbidity. Physiol Rev 74:761–811
Huxley R, Mendis S, Zheleznyakov E et al (2010) Body mass index, waist circumference and waist: hip ratio as predictors of cardiovascular risk—a review of the literature. Eur J Clin Nutr 16–22
Mottillo S, Filion KB, Genest J et al (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56:1113–1132
Gong HP, Tan HW, Fang NN et al (2009) Impaired left ventricular systolic and diastolic function in patients with metabolic syndrome as assessed by strain and strain rate imaging. Diabetes Res Clin Pract 83:300–307
Crendal E, Walther G, Vinet A et al (2013) Myocardial deformation and twist mechanics in adults with metabolic syndrome: impact of cumulative metabolic burden. Obesity (Silver Spring) 21:E679–E686
Almeida AL, Teixido-Tura G, Choi EY et al (2014) Metabolic syndrome, strain, and reduced myocardial function: multi-ethnic study of atherosclerosis. Arq Bras Cardiol 102:327–335
Tadic M, Cuspidi C, Majstorovic A et al (2014) Does the metabolic syndrome impact left-ventricular mechanics? A two-dimensional speckle tracking study. J Hypertens 32:1870–1878
Compliance with ethical guidelines
Conflict of interest. Q. Wang, Y. Gao, K. Tan, and P. Li state that there are no conflicts of interest.
All studies on humans described in the present manuscript were carried out with the approval of the responsible ethics committee and in accordance with national law and the Helsinki Declaration of 1975 (in its current, revised form). Informed consent was obtained from all patients included in studies.
Consent was obtained from all patients identifiable from images or other information within the manuscript. In the case of underage patients, consent was obtained from a parent or legal guardian.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, Q., Gao, Y., Tan, K. et al. Subclinical impairment of left ventricular function in diabetic patients with or without obesity. Herz 40 (Suppl 3), 260–268 (2015). https://doi.org/10.1007/s00059-014-4186-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-014-4186-y
Keywords
- Three-dimensional speckle tracking echocardiography
- Myocardial damage
- Left ventricular function
- Type 2 diabetes
- Obesity